Sleep problems are more widely reported in women than men, and women are 1.4 times more likely to experience insomnia than men. To address the specifics of sex differences in sleep disorders, the Society for Women's Health Research (SWHR) hosted the congressional briefing, "Sleep Disorders and You: How challenges to sleep impact every aspect of your life" on April 11.
Martha Nolan, Vice President of Public Policy at SWHR, provided opening remarks and introduced the first panelist, Michael J. Twery, PhD, Director of the National Center on Sleep Disorders Research, National Heart, Lung, and Blood Institute, National Institutes of Health (NIH), who explained that shift work, long work hours, and untreated and chronic sleep disorders are major contributors to America’s sleep deficiency.
Sleep disorders “affect all racial groups and genders,” said Twery. They “increase the risk of stroke, cardiovascular disease, mortality, hypertension, and obesity.” Sleep controls our memory filters, affects our dreams, inspirations, and emotional responses, so not getting enough can be very detrimental to our health.
Helene A. Emsellem, MD, Director of The Center for Sleep & Wake Disorders, discussed specific sex differences in sleep disorders. Because of the different hormonal levels in different trimesters, pregnancy can either increase or decrease sleepiness, and raises the risk of Restless Legs Syndrome (RLS) in the third trimester. Emsellem noted “35-40% of menopausal women report sleep problems as well.”
She further explained that a lack of sleep causes cognitive impairment, difficulty focusing, impaired memory, delayed visual reaction time, and impaired motor function. Men and women should set aside the requisite 7-9 hours for sleep to maintain high cognitive function and motor abilities. Emsellem suggests exercise, maintaining a regular sleep schedule, and other healthy lifestyle habits to help fall and stay asleep.
The final panelist, Ronald Farkas, MD, PhD, Clinical Team Leader, Division of Neurology Products at the Food and Drug Administration (FDA) provided information on sleep drugs and dosing requirements that account for gender differences. Farkas said, “To support FDA approval of drugs for sleep disorders (and most disorders), data is required about potential gender differences in safety and efficacy.”
Zolpidem, the most popular type of sleep drug, has a known gender difference. It’s “known that women clear zolpidem from the body more slowly than men,” said Farkas. Because of this difference, women are prescribed a lower dose than men (1.75 mg for women vs. 3.5 mg for men). According to Farkas, FDA is always reevaluating sleep drugs and data to better serve the public.
Understanding the science of sleep and the influence of sex differences will lead to healthier and more effective treatments for all.
For more information on the Society for Women’s Health Research please contact Rachel Griffith at 202-496-5001 or Rachel@swhr.org.
The Society for Women’s Health Research (SWHR), a national non-profit organization based in Washington D.C., is widely recognized as the thought leader in women’s health research, particularly how sex differences impact health. SWHR’s mission is to improve the health of all women through advocacy, education and research. Visit SWHR’s website at www.swhr.org for more information.
Rachel Griffith | Newswise Science News
Diabetes mellitus: A risk factor for early colorectal cancer
27.05.2020 | Nationales Centrum für Tumorerkrankungen (NCT) Heidelberg
Ultra-thin fibres designed to protect nerves after brain surgery
27.05.2020 | Martin-Luther-Universität Halle-Wittenberg
In living cells, enzymes drive biochemical metabolic processes enabling reactions to take place efficiently. It is this very ability which allows them to be used as catalysts in biotechnology, for example to create chemical products such as pharmaceutics. Researchers now identified an enzyme that, when illuminated with blue light, becomes catalytically active and initiates a reaction that was previously unknown in enzymatics. The study was published in "Nature Communications".
Enzymes: they are the central drivers for biochemical metabolic processes in every living cell, enabling reactions to take place efficiently. It is this very...
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
29.05.2020 | Materials Sciences
29.05.2020 | Materials Sciences
29.05.2020 | Power and Electrical Engineering